Company News
-
Merck to buy Immune Design for $300 million
Company | News | 0 Comment | 22 Feb, 2019
Merck and Immune Design have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Design for $5.85 per share in cash for an approximate value of ...Read more
-
AstraZeneca strengthens innovation partnerships with NASSCOM
Company | News | 0 Comment | 22 Feb, 2019
In order to address the rising burden of Non-Communicable Diseases (NCDs) in India, Leif Johansson, Chairman of the Board, AstraZeneca announced expansion of the company’s strategic c...Read more
-
Supreme Court exempts Saridon from the List of Banned FDCs
Company | News | 0 Comment | 21 Feb, 2019
The Supreme Court of India has ruled in favor of Saridon, a heritage brand from the healthcare product portfolio of Piramal Enterprises Limited (PEL), exempting its formulation from the lis...Read more
-
Company | News | 0 Comment | 20 Feb, 2019
Starting next week, leading pharmaceutical packaging company, SCHOTT KAISHA will host a roadshow in five Indian cities: Chandigarh, Ahmedabad, Mumbai, Bangalore and Hyderabad to ensure that...Read more
-
Thermo Fisher to expand with $35M supply chain facility
Company | News | 0 Comment | 20 Feb, 2019
Thermo Fisher Scientific announces to start construction of a new $35 million state-of-the-art pharma services supply chain facility in Rheinfelden (Baden) Germany. The facility expa...Read more
-
Essilor India unveils Crizal Sapphire 360° UV lenses for Millennial
Company | News | 0 Comment | 19 Feb, 2019
Essilor, who was ranked for the 7th consecutive year by Forbes among the 100 most innovative companies of the world, launched a new lens of Crizal named Crizal Sapphire 360° UV with the...Read more
-
Cipla, Wellthy to offer digital therapeutics for Diabetes, CVDs
Company | News | 0 Comment | 19 Feb, 2019
Cipla Limited and Wellthy Therapeutics have announced that they have entered into a partnership to offer a combination of pharmacotherapy and digital therapeutics for improved patient outco...Read more
-
Alembic Pharma gets USFDA nod for Moxifloxacin Ophthalmic Solution
Company | News | 0 Comment | 18 Feb, 2019
Alembic Pharmaceuticals Limited (Alembic) announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Moxiflox...Read more
-
Bharat Biotech acquires Chiron Behring Vaccines
Company | News | 0 Comment | 18 Feb, 2019
Bharat Biotech has announced the forthcoming acquisition of Chiron Behring Vaccines Pvt Ltd, located in Ankleshwar, Gujarat from GlaxoSmithKline Asia. Bharat Biotech will acquire 100% equit...Read more
-
Lupin launches Tadalafil Tablets
Company | News | 0 Comment | 13 Feb, 2019
Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tadalafi...Read more
-
Lupin receives FDA approval for Fluoxetine Tablets
Company | News | 0 Comment | 13 Feb, 2019
Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States Food and Drug Administration (FDA) to market a generic version of Alv...Read more
-
Dr. Reddy's launches Tadalafil Tablets
Company | News | 0 Comment | 12 Feb, 2019
Dr. Reddy’s Laboratories has announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tadalafil) Tablets in the United States market, a...Read more
-
USFDA completes inspection of Lupin’s Goa facility
Company | News | 0 Comment | 12 Feb, 2019
Pharma major Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection at its Goa manufacturing facility. The inspection was carried out between...Read more
-
Glenmark receives ANDA approval for Sevelamer Hydrochloride Tablets
Company | News | 0 Comment | 11 Feb, 2019
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Ren...Read more
-
Lupin receives FDA approval for Tadalafil
Company | News | 0 Comment | 07 Feb, 2019
Pharma major Lupin announced that it has received approval for its Tadalafil Tablets USP, 20 mg from the United States Food and Drug Administration (FDA) to market a generic version of Eli ...Read more
-
Glenmark receives tentative ANDA approval for Fulvestrant
Company | News | 0 Comment | 07 Feb, 2019
Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL), a generic vers...Read more
-
Cipla receives final approval for generic version of Adcirca
Company | News | 0 Comment | 07 Feb, 2019
Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Tadalafil Tablets 20mg from the United States Food and Drug Administratio...Read more
-
Glenmark Pharma signs an agreement with Grandpharma
Company | News | 0 Comment | 06 Feb, 2019
Glenmark Pharmaceuticals has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Grandpharma (China) Co. Ltd. for commercial...Read more
